MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from exercise of
warrants
$4,639K
Proceeds from issuance of
debt
$1,400K
Proceeds from issuance of
warrants
$567K
Proceeds from issuance of
common stock
$342K
Net cash provided by
financing activities
$6,109K
Canceled cashflow
$810K
Net increase
(decrease) in cash and cash...
$81K
Canceled cashflow
$6,028K
Payments for issuance
costs
$487K
Reduction of debt
liability
$309K
Reduction of finance lease
liability
$14K
Fair value of common
stock issued to...
$514K
Depreciation and
amortization
$454K
Other liabilities
$385K
Accounts payable
$318K
Stock-based compensation
expense
$151K
Accrued expenses
$125K
Paid-in-kind interest
expense on promissory...
$40K
Operating lease
liabilities, net
$18K
Contract liability
$16K
Net cash used in
operating activities
-$6,010K
Net cash used in
investing activities
-$18K
Canceled cashflow
$2,021K
Net loss
-$7,751K
Acquisitions of property and
equipment
$18K
Accounts receivable,
$188K
Prepaid expenses and
other current assets
$166K
Back
Back
Cash Flow
Vivos Therapeutics, Inc. (VVOS)
Vivos Therapeutics, Inc. (VVOS)
source: myfinsight.com